Genentech takes the health and safety of our patients, customers, employees and local communities very seriously, and we are actively responding to the global COVID-19 pandemic. For more, please visit our COVID-19 response page or call 1-877-436-3683.

Colby Shemesh - Principal Scientist Development, Clinical Pharmacology

Colby Shemesh

Principal Scientist Development, Clinical Pharmacology

"I feel a great sense of meaning from my work and am privileged to be working for Genentech as a clinical pharmacologist lead on many transformative programs."
Years at Genentech
Awards & Honors

Prior to joining Genentech, I worked at Novartis and Ionis Pharmaceuticals supporting the development of several large and complex molecules. At Genentech I have been supporting the Oncology Clinical Pharmacology strategy for several combination cancer immunotherapy programs. Some of the clinical development areas I have worked on include Phase 1-3 studies, special population assessments, organ impairment, material bridging, pediatric studies, ethnic sensitivity, and drug-drug interaction liabilities.

The work environment and culture of Genentech have been a place of constant stimulation, positive energy, and passion for me. Developing transformative medicines and offering new hopes for patients are Genentech’s top priorities and commitments. In this short time, I have already had the privilege to sense the impact of my work and am continuously being challenged with excellent opportunities to learn and grow, and have established a strong connection and sense of pride to be a member of Genentech family.

Featured Publication

Pharmacokinetic and Pharmacodynamic Investigations for Antisense Oligonucleotides Using Alpha-2-Macroglobulin and Murinoglobulin Double-Knockout Mice.

Nucleic Acid Therapeutics 26:223-35.

Shemesh CS, Yu R, Gaus H, Seth P, Bennett F, Geary R, Henry S, and Wang Y. (2016).